This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
CHMFL-FLT3-122 is an inhibitor of FMS-related tyrosine kinase 3 (FLT3, IC50 = 40 nM). It is selective for FLT3 over Bruton's tyrosine kinase (BTK) and C-Kit (IC50s = 421 and 559 nM, respectively) and a panel of 468 additional kinases at 1 µM. CHMFL-FLT3-122 inhibits the growth of MV4-11, MOLM-13, and MOLM-14 acute myeloid leukemia (AML) cells containing FLT3 bearing an internal-tandem duplication (FLT3-ITD, GI50s = 22, 21, and 42 nM, respectively). In vivo, CHMFL-FLT3-122 (50 mg/kg) inhibits tumor growth in an MV4-11 mouse xenograft model.. Solulibility: Acetonitrile: Slightly soluble: 0.1-1 mg/ml: DMSO: Slightly soluble: 0.1-1 mg/ml.
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the usability of this website, serve for direct advertising or simplify interaction with other websites and social networks, will only be used with your consent.
More information